OPPS
This article was originally published in The Gray Sheet
Executive Summary
Datascope's collagen-based Vasoseal is not included on the Health Care Financing Administration's list of devices eligible for reimbursement under the hospital outpatient prospective payment system. Competitor Kensey-Nash's Angioseal closure device is included on the list. St. Jude acquired marketing and manufacturing rights to Angioseal in February 1999 (1"The Gray Sheet" Feb. 8, 1999, p. 15). "The Gray Sheet" previously reported the device was not on the list